>
Switch to:

Allergy Therapeutics Price-to-Tangible-Book

: 5.30 (As of Today)
View and export this data going back to 2004. Start your Free Trial

As of today (2021-10-25), Allergy Therapeutics's share price is $0.498. Allergy Therapeutics's Tangible Book per Share of Jun. 2021 for the quarter that ended in Jun. 2021 was $0.09. Hence, Allergy Therapeutics's Price to Tangible Book Ratio of today is 5.30.

The historical rank and industry rank for Allergy Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

OTCPK:AGYTF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.3   Med: 3.97   Max: 57.5
Current: 4.98

2.3
57.5

During the past 13 years, Allergy Therapeutics's highest Price to Tangible Book Ratio was 57.50. The lowest was 2.30. And the median was 3.97.

OTCPK:AGYTF's Price-to-Tangible-Book is ranked higher than
60% of the 134 Companies
in the Drug Manufacturers industry.

( Industry Median: 5.01 vs. OTCPK:AGYTF: 4.98 )

A closely related ratio is called PB Ratio. As of today, Allergy Therapeutics's share price is $0.498. Allergy Therapeutics's Book Value per Sharefor the quarter that ended in Jun. 2021 was $0.10. Hence, Allergy Therapeutics's P/B Ratio of today is 4.79.


Allergy Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Allergy Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Price-to-Tangible-Book
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.23 7.50 2.62 1.95 2.45

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Price-to-Tangible-Book Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.62 1.77 1.95 0.88 2.45

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Allergy Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Allergy Therapeutics Price-to-Tangible-Book Distribution

For the Drug Manufacturers industry and Healthcare sector, Allergy Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Allergy Therapeutics's Price-to-Tangible-Book falls into.



Allergy Therapeutics Price-to-Tangible-Book Calculation

Allergy Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2021 )
=0.498/0.094
=5.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Allergy Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)